Answers are grounded in this paper and cite their sources.
Two recent studies test whether oligonucleotide drugs that are tailored to target different cell types — the hepatocyte and the myocyte and cardiomyocyte — actually target those cell types.
No takes yet. Share an insight, caveat, or question.
Arthur A. Levin (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: